<SEC-DOCUMENT>0001104659-22-085788-index.html : 20220803 <SEC-HEADER>0001104659-22-085788.hdr.sgml : 20220803 <ACCEPTANCE-DATETIME>20220803214650 ACCESSION NUMBER: 0001104659-22-085788 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220731 FILED AS OF DATE: 20220803 DATE AS OF CHANGE: 20220803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dalton Lisa CENTRAL INDEX KEY: 0001732196 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 221134359 MAIL ADDRESS: STREET 1: 3737 MARKET STREET, SUITE 1300 CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25-28 NORTH WALL QUAY CITY: DUBLIN STATE: L2 ZIP: D01 H104 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 414 COMMERCE DRIVE STREET 2: STE 120 CITY: FORT WASHINGTON STATE: PA ZIP: 19034 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 </SEC-HEADER> <DOCUMENT> <TYPE>4 <SEQUENCE>1 <FILENAME>tm2222534-3_4seq1.xml <DESCRIPTION>OWNERSHIP DOCUMENT <TEXT> Document 1 - file: tm2222534-3_4seq1.html
Document 1 - RAW XML: tm2222534-3_4seq1.xml
</DOCUMENT> </SEC-DOCUMENT>